The Role of Hyperthermia in Regional Alkylating Agent Chemotherapy
Open Access
- 1 September 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (17) , 5919-5929
- https://doi.org/10.1158/1078-0432.ccr-04-0096
Abstract
The role of hyperthermia during regional alkylating agent chemotherapy is controversial. The aim of this study was to determine the exact contribution of hyperthermia to tumor response during isolated limb infusion with l-phenylalanine mustard. Rats bearing rodent fibrosarcoma on the hindlimb underwent isolated limb infusion with saline, saline plus heat, l-phenylalanine mustard, l-phenylalanine mustard under conditions of normothermia, or l-phenylalanine mustard plus hyperthermia. Heat was administered locally using an in-line hot water circulation loop. Treatment with l-phenylalanine mustard at a concentration of 15 or 50 μg/mL was ineffective at producing tumor growth delay (P = 0.24 and 0.41, respectively). Furthermore, thermal enhancement of l-phenylalanine mustard activity was not seen at 15 μg/mL. However, administration of high-dose l-phenylalanine mustard, 50 μg/mL, with increasing amounts of heat yielded increasing tumor growth delay, increased regressions, and decreased proliferative index. Although l-phenylalanine mustard infusion under normothermia yielded a tumor growth delay of 7.1 days, combination l-phenylalanine mustard + hyperthermia treatment produced tumor growth delay of 27.0 days (P < 0.01; with two of five animals showing a complete response). Four hours after isolated limb infusion, 50.9% of cells in tumor treated with l-phenylalanine mustard + hyperthermia experienced apoptosis, whereas only 18.1, 16, and 4.4% of cells underwent apoptosis after treatment with l-phenylalanine mustard, saline + hyperthermia, or saline. The mean concentration of l-phenylalanine mustard within tumor relative to perfusate following isolated limb infusion was found to be similar among all groups at 0.023, 0.025, and 0.032 in animals undergoing isolated limb infusion with l-phenylalanine mustard, l-phenylalanine mustard + normothermia, and l-phenylalanine mustard + hyperthermia, respectively. These data indicate a synergistic cytotoxic effect of l-phenylalanine mustard + hyperthermia in isolated limb infusion, which is not attributable to enhanced tumor drug uptake.Keywords
This publication has 36 references indexed in Scilit:
- In-transit melanoma: The role of alkylating-agent resistance in regional therapy1Journal of the American College of Surgeons, 2004
- The cellular and molecular basis of hyperthermiaCritical Reviews in Oncology/Hematology, 2002
- Apoptosis: A Link between Cancer Genetics and ChemotherapyPublished by Elsevier ,2002
- Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitroInternational Journal of Hyperthermia, 2002
- Using units of CEM 43°C T90, local hyperthermia thermal dose can be delivered as prescribedInternational Journal of Hyperthermia, 2000
- Invited Review: For the clinical application of thermochemotherapy given at mild temperaturesInternational Journal of Hyperthermia, 1999
- Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinomaInternational Journal of Cancer, 1998
- Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusionSeminars in Surgical Oncology, 1998
- A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremitiesEuropean Journal Of Cancer, 1995
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992